OBJECTIVE: To compare the efficacy of two regimens (21 active pills + 7 placebo pills vs. 24 active pills + 4 placebo pills) of combined oral contraception (COC), both containing 20 μg of ethinyl E(2) and 3 mg of drospirenone, in improving the severity of pure menstrual migraine without aura. DESIGN: Prospective randomized study. SETTING: Patients attending the gynecology department of the University of Siena for consultation regarding an appropriate contraception. PATIENT(S): Women ages 20 to 35 years (n = 60) suffering from pure menstrual migraine without aura. INTERVENTION(S): Three months of contraceptive use (ethinyl E(2) 20 μg/drospirenone 3 mg) in two different regimens: group A received 21 active + 7 placebo pills whereas group B received 24 active + 4 placebo pills. MAIN OUTCOME MEASURE(S): Monthly evaluation of the duration and severity of patients' daily headache attacks. RESULT(S): Although both study groups demonstrated significant reduction in the intensity and duration of menstrual migraine, patients in group B (24/4 COC) reported a significant reduction in the intensity and a shorter duration of their menstrual migraine, compared with group A (21/7 COC). CONCLUSION(S): The 24/4 COC regimen is recommended as the preferred treatment for patients suffering from pure menstrual migraine without aura.

De Leo, V., Scolaro, V., Musacchio, M.C., Di Sabatino, A., Morgante, G., Cianci, A. (2011). Combined oral contraceptives in women with menstrual migraine without aura. FERTILITY AND STERILITY, 96(4), 917-920 [10.1016/j.fertnstert.2011.07.1089].

Combined oral contraceptives in women with menstrual migraine without aura

De Leo, V.;Scolaro, V.;Morgante, G.;
2011-01-01

Abstract

OBJECTIVE: To compare the efficacy of two regimens (21 active pills + 7 placebo pills vs. 24 active pills + 4 placebo pills) of combined oral contraception (COC), both containing 20 μg of ethinyl E(2) and 3 mg of drospirenone, in improving the severity of pure menstrual migraine without aura. DESIGN: Prospective randomized study. SETTING: Patients attending the gynecology department of the University of Siena for consultation regarding an appropriate contraception. PATIENT(S): Women ages 20 to 35 years (n = 60) suffering from pure menstrual migraine without aura. INTERVENTION(S): Three months of contraceptive use (ethinyl E(2) 20 μg/drospirenone 3 mg) in two different regimens: group A received 21 active + 7 placebo pills whereas group B received 24 active + 4 placebo pills. MAIN OUTCOME MEASURE(S): Monthly evaluation of the duration and severity of patients' daily headache attacks. RESULT(S): Although both study groups demonstrated significant reduction in the intensity and duration of menstrual migraine, patients in group B (24/4 COC) reported a significant reduction in the intensity and a shorter duration of their menstrual migraine, compared with group A (21/7 COC). CONCLUSION(S): The 24/4 COC regimen is recommended as the preferred treatment for patients suffering from pure menstrual migraine without aura.
De Leo, V., Scolaro, V., Musacchio, M.C., Di Sabatino, A., Morgante, G., Cianci, A. (2011). Combined oral contraceptives in women with menstrual migraine without aura. FERTILITY AND STERILITY, 96(4), 917-920 [10.1016/j.fertnstert.2011.07.1089].
File in questo prodotto:
File Dimensione Formato  
Combined oral contraceptives in women with.pdf

non disponibili

Tipologia: Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 555.88 kB
Formato Adobe PDF
555.88 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/29652
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo